Article thumbnail

Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer

By J Ferlay, CN Sternberg, M Ploeg, MC Hall, H Maase von der, TT Sio, Y Miyata, FA Pla, SM Wilhelm, NM Harn, CA Grandinetti, L Deng, S Krege, EA Eisenhauer, M Ghosh, G Philips, SS Sridhar, R Dreicer, T Powles, A Rose and J Knievel
Publisher: 'Springer Science and Business Media LLC'
DOI identifier: 10.1007/s12032-015-0683-y
OAI identifier:
Provided by: MUCC (Crossref)

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.